SABS Earnings SAB Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.35 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -0.79 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | -0.33 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.65 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.56 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -3.68 | 2026-03-09 | 10-K |
| Q3 2025 | 2024-09-30 | -2.45 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.34 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.54 | 2025-05-09 | 10-Q |
| FY 2024 | 2023-12-31 | -7.64 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -3.79 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.82 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.46 | 2024-05-20 | 10-Q |
| FY 2023 | 2022-12-31 | -4.31 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | -0.25 | 2023-11-13 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.09 | 2022-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.02 | 2023-05-15 | 10-Q |
| FY 2021 | 2021-12-31 | -0.63 | 2022-03-29 | 10-K |
| Q3 2022 | 2021-09-30 | -0.22 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.06 | 2022-08-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.